Actual
#1 in Business Subscribe Email Print

You are here: Home > Computers and Technology > Hardware > To Prototype or Not to Prototype

Tags

  • conducted
  • regulatory
  • before
  • developing combination
  • companies involved
  • combination products

  • Links

  • Interpreting College Writing Assignments: What's Your Professor Asking You to Do?
  • You Are The Actor or Actress Of Your Own Story
  • Mercedes-Benz Innovative 4MATIC Commercial
  • Actual - To Prototype or Not to Prototype

    Simply put, prototyping is creating a functional and easily modifiable model, simulation or demonstration of a product such as a software.

    Prototypin
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    g can be done before, during and later stages of developing the product. It is conducted before the start of the developing process to show that the c
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    oncept is attainable, useful for the intended clientele and beneficial for the company.

    Also by conducting prototyping at the beginning, the develope
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    s will know what specifications are needed and what features are preferred to be included in the final output.

    Meanwhile, by conducting prototyping d
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    uring the developing process, the developers will have an opportunity to check if the product is meeting all features and specifications and will have
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    a chance to evolve these product characteristics into a better output.

    When conducted in the later stages, prototyping can determine problems and po
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    sible solutions on the functionality of the product’s design. It allows changes to be made and various solutions to be implemented just before the ful
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    l product version is released.

    One uses prototyping in order to lessen the communication gap between the developers and the target clients. Prototypi
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ng improves the communication flow which can increase the chance that the customers will accept the final product.

    Prototyping is also used to clarif
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    misconceptions about the product, assure output quality, manage alterations, increase user participation, gather valid specifications, and address va
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    rious product issues like visibility and negative publications.

    Even though prototyping can be done on mostly any project endeavor you will have to p
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    erform the process at the right time, at the right place and using the appropriate tools to achieve a successful and usable prototype. A successful pr
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    totype should be able to test the functionality of the product and evaluate a suggested product interface.

    Prototyping also has a higher rate of succ
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ess if it is utilized to compare various product designs, to explore results of design alterations, to identify market needs, to involve end users in
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    the designing workflow, to draw out any fresh, possible or unexpected elements into the design, and if it is used later on to construct a larger and m
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    re complex model.

    On the other hand, when your prototyping proved to be unsuccessful it’s most likely that you failed to create a clear set of criter
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ia that would have determined when to end the prototyping process.

    Prototyping failure also means that the consumer’s expectations were all accommoda
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ted which allowed it to go out of hand. If you applied all the operational functions of the prototype to the larger and final product and you find the
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    lacking or did not meet product expectations then it means you made some errors during the prototyping process. It is also wrong to use prototyping t
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    o measure the future performance of a system that is still in the planning stage or use it as a marketing tool for a product that exists only on paper


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.actual.org.ua/article/173583/actual-To-Prototype-or-Not-to-Prototype.html">To Prototype or Not to Prototype</a>

    BB link (for phorums):
    [url=http://www.actual.org.ua/article/173583/actual-To-Prototype-or-Not-to-Prototype.html]To Prototype or Not to Prototype[/url]

    Related Articles:

    Company Policy Does More Damage to Customer Service Than Anything Else

    Balance Transfer Credit Cards - Which One For You

    A Practical Guide to Understanding Investment Property For Sale In UK

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com